Obesity and Diabetes: From Basic Mechanisms to Treatment
LB-PP02-1
Comparison of Gut Microbiota in Obese, Diabetic and Healthy Control Individuals
Yalcin Basaran, Abdullah Taslipinar, Sinasi Erol Bolu, Mehmet Ali Saracli, Turker Turker, Coskun Meric, Cem Haymana, Kamil Baskoy, Mustafa Dinc, Ferhat Deniz, Mahmut Yazici, Aydogan Aydogdu, Alper Sonmez and Omer Azal
LB-PP02-2
Free Fatty Acid Receptor 2 (FFAR2) Is Important in Mediating the Effects of Fermentable Carbohydrate on Gut Inflammation but Not Intestinal Barrier Function in Obesity
Lucy Brooks, Patrice Cani, Amandine Everard, Stephen R Bloom, Gary Frost and Gavin Bewick
LB-PP02-3
Exenatide Induces an Increase in Vasodilatory Mediators
Ajay Chaudhuri, Husam Ghanim, Sandeep S Dhindsa, Kelly Green, Sanaa Abuaysheh, Antoine Makdissi, Nitesh D Kuhadiya, Manav Batra and Paresh Dandona
LB-PP02-4
ZYDPLA1, a Novel Long-Acting DPP-4 Inhibitor
Mukul R Jain, Amit Arvind Joharapurkar, Rajesh Bahekar, Harilal Patel, Samadhan Kshirsagar, Pradip Jadav, Vishal Patel, Kartikkumar Patel, Vikram K Ramanathan, Pankaj R Patel and Ranjit Desai